HIV Malignancy Specimens for Research at No Charge
Through this Notice of Special Interest (NOSI), NOT-CA-23-070 the National Cancer Institute (NCI) is a continuation of NOT-CA-20-022, “High” or “Medium” Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers, which expired …
Discovery from researchers at Dana Farber Cancer Center and collaborators opens the way to drugs that can prevent T-cell therapies from losing their potency over time. Read more about the …
The ACSR is proud to celebrate Arti Vashist, Fall 2021 YIPA recipient! Dr. Vashist will be presenting her poster abstract entitled: “Development of vegetable oil-based Micro/nanogels as versatile system for …
(From the CFAR Adelante RFA: https://cfar-adelante.org/wp-content/uploads/2022/08/Adelante.RFA-CohortV_FINAL-081522.pdf) As confirmed by the National Ending the HIV Epidemic in the U.S. (EHE) Initiative, there has been adearth of culturally responsive research specific to …
Use of stem cells for research has not be conducted without its share of controversy. New research using a new transplant method involving umbilical cord blood, presented at this year’s …
How do HIV/AIDS & cancer research continue to converge? Read more about the early results from a novel study which shows that pembrolizumab, a cancer drug, can flush HIV from …
Did you know some of the earliest AIDS patient care & research was performed by National Cancer Institute scientists & external researchers funded by NCI? Read how cancer research led to …